Status:
UNKNOWN
Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)
Lead Sponsor:
Newcastle-upon-Tyne Hospitals NHS Trust
Collaborating Sponsors:
Alder Hey Children's NHS Foundation Trust
National Institute for Health Research, United Kingdom
Conditions:
Recurrent Respiratory Papillomatosis
Human Papilloma Virus
Eligibility:
All Genders
Brief Summary
Recurrent Respiratory Papillomatosis (RRP) causes wart-like growths in the airway which can make it difficult to breathe, speak and carry out normal everyday activities. It is a rare condition affecti...
Detailed Description
Primary aim: The overall goal is to improve the care of patients with Recurrent Respiratory Papillomatosis (RRP) - and the investigators aim to do this by determining the most effective and safe RRP ...
Eligibility Criteria
Inclusion
- patients of any age (no restrictions) diagnosed with (newly diagnosed or existing) and receiving treatment for respiratory papillomatosis
- informed assent/consent of data participation provided by patient/parent/guardian
Exclusion
- patients participating in other studies
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03465280
Start Date
April 1 2018
End Date
August 31 2022
Last Update
January 11 2022
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS Grampian
Aberdeen, United Kingdom, AB25 2ZB
2
Betsi Cadwaladr University Health Board,
Bangor, United Kingdom, LL57 2PW
3
Basildon & Thurrock University Hospitals NHS FT
Basildon, United Kingdom, SS165NL
4
Belfast Health and Social Care Trust
Belfast, United Kingdom, BT2 8BG